MarketInOut Stock Screener Log In | Sign Up

Emcure Pharmaceuticals Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Emcure Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization352,397 mln
Float35.26 mln
Earnings Date11/03/2026

EPS

53.40
Exceptional

P / E

34.87
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.32
Borderline

1-Year Forecast

2,229.38
Attractive

Relative Strength

82 / 100
Strongly outperforming

Business Description

Founded in Pune, India in 1981, Emcure Pharmaceuticals develops and sells medicines across a wide range of health conditions, from heart disease and diabetes to cancer and HIV, serving patients in markets around the world. The company markets its treatments under several well-known brand names and has recently partnered with Novo Nordisk India to bring a weight-loss injection called Poviztra to patients.

Key Fundamentals

EPS53.40
P/E34.87
ROE21.46
RPS511
ROIC15.18
ROA11.02
Interest Cover9.89
EBITDA, mln19,635
EV / EBITDA17.92
EV / EBIT22.87
Revenue, mln96,834
EV / Revenue3.63

Quote Details

Last 1,862.00
Change -3.1 (-0.17%)
Open 1,862.05
Volume 2,043
Turnover 3,804,066
Average Volume 6,693.05

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio1.43
Price / Book7.18
Price / Tangible Book9.24
Price / Free Cash Flow72.53
Debt / Equity0.31
Price / Sales3.67
PEG Ratio1.87

Financial Strength

Altman Z-Score6.47
Piotroski F-Score 5 / 9
Beneish M-Score-2.32
Price to Intrinsic Value3.95
Price to Lynch Fair Value2.01
Price to Graham Number3.87
1-Year Target Price2,229.38
Shiller PE Ratio41.62

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.31% 76 / 100   
1 Month -4.99% 56 / 100   
2 Months -0.28% 68 / 100   
6 Months 7.66% 73 / 100   
1 Year 35.18% 88 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog